Rheumatology Academy

Where education meets excellence.
The latest rheumatology CME
& clinical updates you need.

Where education meets excellence.
The latest rheumatology CME & clinical updates you need.

Navigating the Modern PsA Treatment Landscape
Navigating the Modern PsA Treatment Landscape
Living Rheum
Navigating the Modern PsA Treatment Landscape
Molecular Signals and Early Detection in Psoriatic Arthritis
Molecular Signals and Early Detection in Psoriatic Arthritis
Living Rheum
Molecular Signals and Early Detection in Psoriatic Arthritis
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
AudioAbstracts
Can FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
- Ryan Quigley
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Living Rheum
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
- Steve Jackson, PharmD
- Marc Scherlinger, MD, PhD
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living Rheum
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
- Ryan Quigley
- Luigi Adamo, MD, PhD
- Andrea Fava, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living Rheum
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
- Gary S. Firestein, MD
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living Rheum
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
- Ryan Quigley
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Living Rheum
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers